Federal contract award
75N93019F00132
75N93019D00031; JOHNS HOPKINS UNIVERSITY; FY19; TO #001 RSV; POP 9/5/19-6/30/21; EVALUATION OF LIVE ATTENUATED PEDIATRIC RSV VACCINES FOR FISCAL YEAR (FY) 2019 RSV SEASON
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AJ52 — LIFE SCIENCES - APPLIED RESEARCH/EXPLORATORY DEVELOPMENT |
| Parent award / vehicle | 75N93019D00031 |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $12.8M |
| Current contract value | $12.8M |
| Potential contract value / ceiling | $12.8M |
| Start date | Sep 5, 2019 |
| Current end date | Mar 31, 2025 |
| Potential end date | Mar 31, 2025 |
| Latest award activity | Nov 19, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Nov 19, 2024 | P00006 | $0 | EVALUATION OF LIVE-ATTENUATED PEDIATRIC RSV VACCINES FOR FISCAL YEAR (FY) 2019 RSV SEASON |
| May 13, 2024 | P00005 | $0 | EVALUATION OF LIVE-ATTENUATED PEDIATRIC RSV VACCINES FOR FISCAL YEAR (FY) 2019 RSV SEASON |
| Jun 29, 2022 | P00004 | $5.8M | EVALUATION OF LIVE-ATTENUATED PEDIATRIC RSV VACCINES FOR FISCAL YEAR (FY) 2019 RSV SEASON |
| Jun 16, 2021 | P00003 | $586.1K | EVALUATION OF LIVE-ATTENUATED PEDIATRIC RSV VACCINES FOR FISCAL YEAR (FY) 2019 RSV SEASON |
| Sep 30, 2019 | P00001 | $3.3M | 75N93019D00031; JOHNS HOPKINS UNIVERSITY; FY19; TO #001 RSV; POP 9/5/19-6/30/21; EVALUATION OF LIVE ATTENUATED PEDIATRIC RSV VACCINES FOR FISCAL YEAR (FY) 2019 RSV SEASON |
| Sep 30, 2019 | P00002 | $-3.3M | 75N93019D00031; JOHNS HOPKINS UNIVERSITY; FY19; TO #001 RSV; POP 9/5/19-6/30/21; EVALUATION OF LIVE ATTENUATED PEDIATRIC RSV VACCINES FOR FISCAL YEAR (FY) 2019 RSV SEASON |
| Sep 4, 2019 | 0 | $6.5M | 75N93019D00031; JOHNS HOPKINS UNIVERSITY; FY19; TO #001 RSV; POP 9/5/19-6/30/21; EVALUATION OF LIVE ATTENUATED PEDIATRIC RSV VACCINES FOR FISCAL YEAR (FY) 2019 RSV SEASON |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.